SCHEMBL2051291

SCHEMBL2051291

COc1nccc(C(=O)N(C)[C@H](CCNC(=O)c2cccc(C)n2)Cc2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.43
HCRTR2 O43614 2/20 0.43
HTR1A P08908 1/20 0.38
HTR2A P28223 1/20 0.38
DRD3 P35462 1/20 0.38
OPRM1 P35372 4/20 0.37
OPRK1 P41145 3/20 0.37
EPHX2 P34913 1/20 0.36
SIGMAR1 Q99720 3/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TMEM97 Q5BJF2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
P2RX7 Q99572 1/20 0.35
CTSA P10619 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014592 1.00 HCRTR1 (0.43) HCRTR1HCRTR2HTR1AHTR2ADRD3
SCHEMBL6919106 0.91 HCRTR1 (0.43) HCRTR1HCRTR2HTR1AHTR2ADRD3
SCHEMBL2017304 0.91 HCRTR1 (0.43) HCRTR1HCRTR2HTR1AHTR2ADRD3
SCHEMBL2014812 0.89 HCRTR1 (0.43) HCRTR1HCRTR2HTR1AHTR2AOPRM1
SCHEMBL2014681 0.89 HCRTR1 (0.43) HCRTR1HCRTR2HTR1AHTR2AOPRM1
SCHEMBL2011408 0.84 HCRTR1 (0.43) HCRTR1HCRTR2HTR1AHTR2ADRD3
SCHEMBL2012798 0.83 HCRTR1 (0.48) HCRTR1HCRTR2HTR1AHTR2ADRD3
SCHEMBL2052690 0.83 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2016348 0.83 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2012684 0.81 HCRTR1 (0.42) HCRTR1HCRTR2MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed